Varex Imaging Corporation
NASDAQ:VREXMedical - Devices
+$0.34 today
- Market cap
- $770.71M
- Beta
- 0.90
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.97
Volume 0.73M
Average 0.36M
VREX Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Varex Imaging CorporationNASDAQ: VREX
Depreciation & Amortization · Q2 FY2026 · quarter ended Apr 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $6.8M rose 3.0% year over year, ahead of the -0.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -6.8% a year.
Context
- Depreciation & amortization amounted to 3.2% of revenue in FY2025, down 0.6 pp from a year earlier.
- Depreciation & amortization increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +3.0% holds above the trailing-twelve-month pace of -0.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 27.2M USD
- Year-over-year change
- -12.5%
- 4-year CAGR
- -7.6%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-10-03 | 27.2M | -12.5% |
| FY2024 | 2024-09-27 | 31.1M | -6.3% |
| FY2023 | 2023-09-29 | 33.2M | -1.2% |
| FY2022 | 2022-09-30 | 33.6M | -9.9% |
| FY2021 | 2021-10-01 | 37.3M | — |
Depreciation & Amortization vs competitors
How VREX compares with its peers on the latest reported figures
- VREX's LTM Apr 2026 depreciation & amortization of $27.1M is the 4th largest of the 5 companies compared; the peer median is $136.38M.
- Its year-over-year change of -0.7% is the 4th highest of 5, against a peer median of +3.4%.
- Depreciation & amortization amounts to 3.2% of revenue for VREX, versus a peer median of 4.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $607M | +7.1% | -3.0% | 3.0% | |
| LTM Jun 2026 | $230.1M | +9.4% | +35.4% | 6.6% | |
| LTM Jun 2026 | $42.65M | -2.1% | +3.5% | 2.4% | |
| LTM Apr 2026 | $27.1M | -0.7% | -6.8% | 3.2% | |
| LTM Dec 2025 | $11.7M | -0.3% | +0.5% | 89.8% | |
| Peer median (excluding VREX) | $136.38M | +3.4% | +2.0% | 4.8% | |
Competitors are the stored peer set for VREX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Oct 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Oct 2025 |
|---|---|---|---|---|---|
| Net Income | 17.9M | 30.8M | 48.7M | (47.2M) | (69.9M) |
| Depreciation & Amortization | 37.3M | 33.6M | 33.2M | 31.1M | 27.2M |
| Deferred Income Tax | (3M) | 600K | (39.5M) | 37M | (500K) |
| Stock-Based Compensation | 13.9M | 14M | 13.5M | 15.3M | 15M |
| Change in Working Capital | 8.2M | (88M) | 23.3M | 2M | (31.4M) |
| Accounts Receivables | (32.9M) | (18.1M) | 9.8M | 6.7M | 100K |
| Inventory | 42.8M | (85M) | 20.2M | 6.6M | (39.9M) |
| Accounts Payables | (13.6M) | 19.7M | (15M) | (3.2M) | 6.2M |
| Other Working Capital | 11.9M | (4.6M) | 8.3M | (8.1M) | 2.2M |
| Other Non-Cash Items | 18.3M | 25.9M | 29.2M | 9.1M | 101.3M |
| Operating Cash Flow | 92.6M | 16.9M | 108.4M | 47.3M | 41.7M |
| Capital Expenditures | (15.1M) | (21.3M) | (20.7M) | (26.9M) | (22.9M) |
| Acquisitions (Net) | (1.4M) | 1.1M | (1M) | 900K | 0 |
| Purchases of Investments | 0 | (28.3M) | (55.9M) | (61M) | (31.4M) |
| Sales of Investments | 0 | 2M | 28.3M | 60.6M | 65.4M |
| Other Investing Activities | 300K | (1.9M) | 4.4M | (1.1M) | (800K) |
| Investing Cash Flow | (16.2M) | (48.4M) | (44.9M) | (27.5M) | 10.3M |
| Debt Repayment | (31.6M) | (29.4M) | (2.4M) | (1.6M) | (75M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 3.3M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (700K) | 5.6M | 2.2M | (1.7M) | (4.2M) |
| Financing Cash Flow | (32.3M) | (23.8M) | (200K) | (3.3M) | (75.9M) |
| Effect of Forex Changes | (100K) | (200K) | 100K | (100K) | 600K |
| Net Change in Cash | 44M | (55.5M) | 63.4M | 16.4M | (23.3M) |
| Free Cash Flow | 77.5M | (4.4M) | 87.7M | 20.4M | 18.8M |
Varex Imaging Corporation
NASDAQ:VREX
Intrinsic Alpha fair value
Locked
Current Price
$18.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.